表紙
市場調查報告書

黑色素瘤治療藥的全球市場

Melanoma Therapeutics

出版商 Global Industry Analysts, Inc. 商品編碼 912750
出版日期 內容資訊 英文 252 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
黑色素瘤治療藥的全球市場 Melanoma Therapeutics
出版日期: 2019年10月01日內容資訊: 英文 252 Pages
簡介

本報告提供全球黑色素瘤治療藥市場概要,彙整趨勢·發展的影響因素分析,競爭企業與市場佔有率,世界及地區·各主要國家的市場規模的變化與預測,主要企業簡介等資訊。

第1章 調查手法

第2章 摘要整理

  • 市場概要
    • 全球市場的企業佔有率
    • 全球黑色素瘤治療藥市場上企業佔有率方案
  • 主要企業
  • 市場趨勢與發展因素
  • 全球市場預測

第3章 市場分析

  • 各地區市場分析
    • 美國
    • 加拿大
    • 日本
    • 中國
    • 歐洲
    • 法國
    • 德國
    • 義大利
    • 英國
    • 西班牙
    • 俄羅斯
    • 其他歐洲
    • 亞太地區
    • 澳洲
    • 印度
    • 韓國
    • 其他亞太地區
    • 南美
    • 阿根廷
    • 巴西
    • 墨西哥
    • 其他南美國家
    • 中東
    • 伊朗
    • 以色列
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東
    • 非洲

第4章 競爭企業

  • AMGEN
  • ASTRAZENECA PLC
  • BRISTOL-MYERS SQUIBB COMPANY
  • Eisai
  • F. HOFFMANN-LA ROCHE AG
  • IOVANCE BIOTHERAPEUTICS, INC.
  • MERCK & CO., INC.
  • NOVARTIS INTERNATIONAL AG
  • PFIZER

第5章 調查資料

目錄
Product Code: MCP-6303

Melanoma Therapeutics market worldwide is projected to grow by US$3.9 Billion, driven by a compounded growth of 12.4%. Cutaneous Melanoma, one of the segments analyzed and sized in this study, displays the potential to grow at over 12.2%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$3.1 Billion by the year 2025, Cutaneous Melanoma will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 11% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$152.5 Million to the region's size and clout in the next 5 to 6 years. Over US$127.5 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Cutaneous Melanoma will reach a market size of US$158.4 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 15.8% over the next couple of years and add approximately US$924 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,, Amgen, Inc.; AstraZeneca PLC; Bristol-Myers Squibb Company; Eisai Co., Ltd.; F. Hoffmann-La Roche AG; Iovance Biotherapeutics, Inc.; Merck & Co., Inc.; Novartis International AG; Pfizer, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Melanoma Therapeutics Competitor Market Share Scenario Worldwide (in %): 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Melanoma Therapeutics Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 2: Melanoma Therapeutics Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
  • TABLE 3: Melanoma Therapeutics Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
  • TABLE 4: Cutaneous Melanoma (Type) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 5: Cutaneous Melanoma (Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 6: Cutaneous Melanoma (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 7: Ocular Melanoma (Type) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
  • TABLE 8: Ocular Melanoma (Type) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
  • TABLE 9: Ocular Melanoma (Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
  • TABLE 10: Mucosal Melanoma (Type) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
  • TABLE 11: Mucosal Melanoma (Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017
  • TABLE 12: Mucosal Melanoma (Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 13: Surgery (Therapy) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025
  • TABLE 14: Surgery (Therapy) Market Historic Review by Region/Country in US$ Million: 2009 to 2017
  • TABLE 15: Surgery (Therapy) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 16: Immunotherapy (Therapy) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 17: Immunotherapy (Therapy) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 18: Immunotherapy (Therapy) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 19: Targeted Therapy (Therapy) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025
  • TABLE 20: Targeted Therapy (Therapy) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017
  • TABLE 21: Targeted Therapy (Therapy) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 22: Chemotherapy (Therapy) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2018 to 2025
  • TABLE 23: Chemotherapy (Therapy) Global Historic Demand in US$ Million by Region/Country: 2009 to 2017
  • TABLE 24: Chemotherapy (Therapy) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 25: Radiation Therapy (Therapy) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 26: Radiation Therapy (Therapy) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 27: Radiation Therapy (Therapy) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Melanoma Therapeutics Market Share (in %) by Company: 2019 & 2025
    • TABLE 28: United States Melanoma Therapeutics Market Estimates and Projections in US$ Million by Type: 2018 to 2025
    • TABLE 29: Melanoma Therapeutics Market in the United States by Type: A Historic Review in US$ Million for 2009-2017
    • TABLE 30: United States Melanoma Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 31: United States Melanoma Therapeutics Market Estimates and Projections in US$ Million by Therapy: 2018 to 2025
    • TABLE 32: Melanoma Therapeutics Market in the United States by Therapy: A Historic Review in US$ Million for 2009-2017
    • TABLE 33: United States Melanoma Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025
  • CANADA
    • TABLE 34: Canadian Melanoma Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025
    • TABLE 35: Canadian Melanoma Therapeutics Historic Market Review by Type in US$ Million: 2009-2017
    • TABLE 36: Melanoma Therapeutics Market in Canada: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
    • TABLE 37: Canadian Melanoma Therapeutics Market Estimates and Forecasts in US$ Million by Therapy: 2018 to 2025
    • TABLE 38: Canadian Melanoma Therapeutics Historic Market Review by Therapy in US$ Million: 2009-2017
    • TABLE 39: Melanoma Therapeutics Market in Canada: Percentage Share Breakdown of Sales by Therapy for 2009, 2019, and 2025
  • JAPAN
    • TABLE 40: Japanese Market for Melanoma Therapeutics: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025
    • TABLE 41: Melanoma Therapeutics Market in Japan: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017
    • TABLE 42: Japanese Melanoma Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025
    • TABLE 43: Japanese Market for Melanoma Therapeutics: Annual Sales Estimates and Projections in US$ Million by Therapy for the Period 2018-2025
    • TABLE 44: Melanoma Therapeutics Market in Japan: Historic Sales Analysis in US$ Million by Therapy for the Period 2009-2017
    • TABLE 45: Japanese Melanoma Therapeutics Market Share Analysis by Therapy: 2009 VS 2019 VS 2025
  • CHINA
    • TABLE 46: Chinese Melanoma Therapeutics Market Growth Prospects in US$ Million by Type for the Period 2018-2025
    • TABLE 47: Melanoma Therapeutics Historic Market Analysis in China in US$ Million by Type: 2009-2017
    • TABLE 48: Chinese Melanoma Therapeutics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 49: Chinese Melanoma Therapeutics Market Growth Prospects in US$ Million by Therapy for the Period 2018-2025
    • TABLE 50: Melanoma Therapeutics Historic Market Analysis in China in US$ Million by Therapy: 2009-2017
    • TABLE 51: Chinese Melanoma Therapeutics Market by Therapy: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • EUROPE
    • Market Facts & Figures
    • European Melanoma Therapeutics Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • TABLE 52: European Melanoma Therapeutics Market Demand Scenario in US$ Million by Region/Country: 2018-2025
    • TABLE 53: Melanoma Therapeutics Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 54: European Melanoma Therapeutics Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 55: European Melanoma Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018-2025
    • TABLE 56: Melanoma Therapeutics Market in Europe in US$ Million by Type: A Historic Review for the Period 2009-2017
    • TABLE 57: European Melanoma Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 58: European Melanoma Therapeutics Market Estimates and Forecasts in US$ Million by Therapy: 2018-2025
    • TABLE 59: Melanoma Therapeutics Market in Europe in US$ Million by Therapy: A Historic Review for the Period 2009-2017
    • TABLE 60: European Melanoma Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025
  • FRANCE
    • TABLE 61: Melanoma Therapeutics Market in France by Type: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 62: French Melanoma Therapeutics Historic Market Scenario in US$ Million by Type: 2009-2017
    • TABLE 63: French Melanoma Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025
    • TABLE 64: Melanoma Therapeutics Market in France by Therapy: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 65: French Melanoma Therapeutics Historic Market Scenario in US$ Million by Therapy: 2009-2017
    • TABLE 66: French Melanoma Therapeutics Market Share Analysis by Therapy: 2009 VS 2019 VS 2025
  • GERMANY
    • TABLE 67: Melanoma Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
    • TABLE 68: German Melanoma Therapeutics Historic Market Analysis in US$ Million by Type: 2009-2017
    • TABLE 69: German Melanoma Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 70: Melanoma Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Therapy for the Period 2018-2025
    • TABLE 71: German Melanoma Therapeutics Historic Market Analysis in US$ Million by Therapy: 2009-2017
    • TABLE 72: German Melanoma Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025
  • ITALY
    • TABLE 73: Italian Melanoma Therapeutics Market Growth Prospects in US$ Million by Type for the Period 2018-2025
    • TABLE 74: Melanoma Therapeutics Historic Market Analysis in Italy in US$ Million by Type: 2009-2017
    • TABLE 75: Italian Melanoma Therapeutics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 76: Italian Melanoma Therapeutics Market Growth Prospects in US$ Million by Therapy for the Period 2018-2025
    • TABLE 77: Melanoma Therapeutics Historic Market Analysis in Italy in US$ Million by Therapy: 2009-2017
    • TABLE 78: Italian Melanoma Therapeutics Market by Therapy: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED KINGDOM
    • TABLE 79: United Kingdom Market for Melanoma Therapeutics: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025
    • TABLE 80: Melanoma Therapeutics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017
    • TABLE 81: United Kingdom Melanoma Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025
    • TABLE 82: United Kingdom Market for Melanoma Therapeutics: Annual Sales Estimates and Projections in US$ Million by Therapy for the Period 2018-2025
    • TABLE 83: Melanoma Therapeutics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Therapy for the Period 2009-2017
    • TABLE 84: United Kingdom Melanoma Therapeutics Market Share Analysis by Therapy: 2009 VS 2019 VS 2025
  • SPAIN
    • TABLE 85: Spanish Melanoma Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025
    • TABLE 86: Spanish Melanoma Therapeutics Historic Market Review by Type in US$ Million: 2009-2017
    • TABLE 87: Melanoma Therapeutics Market in Spain: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
    • TABLE 88: Spanish Melanoma Therapeutics Market Estimates and Forecasts in US$ Million by Therapy: 2018 to 2025
    • TABLE 89: Spanish Melanoma Therapeutics Historic Market Review by Therapy in US$ Million: 2009-2017
    • TABLE 90: Melanoma Therapeutics Market in Spain: Percentage Share Breakdown of Sales by Therapy for 2009, 2019, and 2025
  • RUSSIA
    • TABLE 91: Russian Melanoma Therapeutics Market Estimates and Projections in US$ Million by Type: 2018 to 2025
    • TABLE 92: Melanoma Therapeutics Market in Russia by Type: A Historic Review in US$ Million for 2009-2017
    • TABLE 93: Russian Melanoma Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 94: Russian Melanoma Therapeutics Market Estimates and Projections in US$ Million by Therapy: 2018 to 2025
    • TABLE 95: Melanoma Therapeutics Market in Russia by Therapy: A Historic Review in US$ Million for 2009-2017
    • TABLE 96: Russian Melanoma Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025
  • REST OF EUROPE
    • TABLE 97: Rest of Europe Melanoma Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018-2025
    • TABLE 98: Melanoma Therapeutics Market in Rest of Europe in US$ Million by Type: A Historic Review for the Period 2009-2017
    • TABLE 99: Rest of Europe Melanoma Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 100: Rest of Europe Melanoma Therapeutics Market Estimates and Forecasts in US$ Million by Therapy: 2018-2025
    • TABLE 101: Melanoma Therapeutics Market in Rest of Europe in US$ Million by Therapy: A Historic Review for the Period 2009-2017
    • TABLE 102: Rest of Europe Melanoma Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025
  • ASIA-PACIFIC
    • TABLE 103: Asia-Pacific Melanoma Therapeutics Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 104: Melanoma Therapeutics Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 105: Asia-Pacific Melanoma Therapeutics Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 106: Melanoma Therapeutics Market in Asia-Pacific by Type: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 107: Asia-Pacific Melanoma Therapeutics Historic Market Scenario in US$ Million by Type: 2009-2017
    • TABLE 108: Asia-Pacific Melanoma Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025
    • TABLE 109: Melanoma Therapeutics Market in Asia-Pacific by Therapy: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 110: Asia-Pacific Melanoma Therapeutics Historic Market Scenario in US$ Million by Therapy: 2009-2017
    • TABLE 111: Asia-Pacific Melanoma Therapeutics Market Share Analysis by Therapy: 2009 VS 2019 VS 2025
  • AUSTRALIA
    • TABLE 112: Melanoma Therapeutics Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
    • TABLE 113: Australian Melanoma Therapeutics Historic Market Analysis in US$ Million by Type: 2009-2017
    • TABLE 114: Australian Melanoma Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 115: Melanoma Therapeutics Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Therapy for the Period 2018-2025
    • TABLE 116: Australian Melanoma Therapeutics Historic Market Analysis in US$ Million by Therapy: 2009-2017
    • TABLE 117: Australian Melanoma Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025
  • INDIA
    • TABLE 118: Indian Melanoma Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025
    • TABLE 119: Indian Melanoma Therapeutics Historic Market Review by Type in US$ Million: 2009-2017
    • TABLE 120: Melanoma Therapeutics Market in India: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
    • TABLE 121: Indian Melanoma Therapeutics Market Estimates and Forecasts in US$ Million by Therapy: 2018 to 2025
    • TABLE 122: Indian Melanoma Therapeutics Historic Market Review by Therapy in US$ Million: 2009-2017
    • TABLE 123: Melanoma Therapeutics Market in India: Percentage Share Breakdown of Sales by Therapy for 2009, 2019, and 2025
  • SOUTH KOREA
    • TABLE 124: Melanoma Therapeutics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
    • TABLE 125: South Korean Melanoma Therapeutics Historic Market Analysis in US$ Million by Type: 2009-2017
    • TABLE 126: Melanoma Therapeutics Market Share Distribution in South Korea by Type: 2009 VS 2019 VS 2025
    • TABLE 127: Melanoma Therapeutics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Therapy for the Period 2018-2025
    • TABLE 128: South Korean Melanoma Therapeutics Historic Market Analysis in US$ Million by Therapy: 2009-2017
    • TABLE 129: Melanoma Therapeutics Market Share Distribution in South Korea by Therapy: 2009 VS 2019 VS 2025
  • REST OF ASIA-PACIFIC
    • TABLE 130: Rest of Asia-Pacific Market for Melanoma Therapeutics: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025
    • TABLE 131: Melanoma Therapeutics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017
    • TABLE 132: Rest of Asia-Pacific Melanoma Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025
    • TABLE 133: Rest of Asia-Pacific Market for Melanoma Therapeutics: Annual Sales Estimates and Projections in US$ Million by Therapy for the Period 2018-2025
    • TABLE 134: Melanoma Therapeutics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Therapy for the Period 2009-2017
    • TABLE 135: Rest of Asia-Pacific Melanoma Therapeutics Market Share Analysis by Therapy: 2009 VS 2019 VS 2025
  • LATIN AMERICA
    • TABLE 136: Latin American Melanoma Therapeutics Market Trends by Region/Country in US$ Million: 2018-2025
    • TABLE 137: Melanoma Therapeutics Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017
    • TABLE 138: Latin American Melanoma Therapeutics Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025
    • TABLE 139: Latin American Melanoma Therapeutics Market Growth Prospects in US$ Million by Type for the Period 2018-2025
    • TABLE 140: Melanoma Therapeutics Historic Market Analysis in Latin America in US$ Million by Type: 2009-2017
    • TABLE 141: Latin American Melanoma Therapeutics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 142: Latin American Melanoma Therapeutics Market Growth Prospects in US$ Million by Therapy for the Period 2018-2025
    • TABLE 143: Melanoma Therapeutics Historic Market Analysis in Latin America in US$ Million by Therapy: 2009-2017
    • TABLE 144: Latin American Melanoma Therapeutics Market by Therapy: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • ARGENTINA
    • TABLE 145: Argentinean Melanoma Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018-2025
    • TABLE 146: Melanoma Therapeutics Market in Argentina in US$ Million by Type: A Historic Review for the Period 2009-2017
    • TABLE 147: Argentinean Melanoma Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 148: Argentinean Melanoma Therapeutics Market Estimates and Forecasts in US$ Million by Therapy: 2018-2025
    • TABLE 149: Melanoma Therapeutics Market in Argentina in US$ Million by Therapy: A Historic Review for the Period 2009-2017
    • TABLE 150: Argentinean Melanoma Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025
  • BRAZIL
    • TABLE 151: Melanoma Therapeutics Market in Brazil by Type: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 152: Brazilian Melanoma Therapeutics Historic Market Scenario in US$ Million by Type: 2009-2017
    • TABLE 153: Brazilian Melanoma Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025
    • TABLE 154: Melanoma Therapeutics Market in Brazil by Therapy: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 155: Brazilian Melanoma Therapeutics Historic Market Scenario in US$ Million by Therapy: 2009-2017
    • TABLE 156: Brazilian Melanoma Therapeutics Market Share Analysis by Therapy: 2009 VS 2019 VS 2025
  • MEXICO
    • TABLE 157: Melanoma Therapeutics Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
    • TABLE 158: Mexican Melanoma Therapeutics Historic Market Analysis in US$ Million by Type: 2009-2017
    • TABLE 159: Mexican Melanoma Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 160: Melanoma Therapeutics Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Therapy for the Period 2018-2025
    • TABLE 161: Mexican Melanoma Therapeutics Historic Market Analysis in US$ Million by Therapy: 2009-2017
    • TABLE 162: Mexican Melanoma Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025
  • REST OF LATIN AMERICA
    • TABLE 163: Rest of Latin America Melanoma Therapeutics Market Estimates and Projections in US$ Million by Type: 2018 to 2025
    • TABLE 164: Melanoma Therapeutics Market in Rest of Latin America by Type: A Historic Review in US$ Million for 2009-2017
    • TABLE 165: Rest of Latin America Melanoma Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 166: Rest of Latin America Melanoma Therapeutics Market Estimates and Projections in US$ Million by Therapy: 2018 to 2025
    • TABLE 167: Melanoma Therapeutics Market in Rest of Latin America by Therapy: A Historic Review in US$ Million for 2009-2017
    • TABLE 168: Rest of Latin America Melanoma Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025
  • MIDDLE EAST
    • TABLE 169: The Middle East Melanoma Therapeutics Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 170: Melanoma Therapeutics Market in the Middle East by Region/Country in US$ Million: 2009-2017
    • TABLE 171: The Middle East Melanoma Therapeutics Market Share Breakdown by Region/Country: 2009, 2019, and 2025
    • TABLE 172: The Middle East Melanoma Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025
    • TABLE 173: The Middle East Melanoma Therapeutics Historic Market by Type in US$ Million: 2009-2017
    • TABLE 174: Melanoma Therapeutics Market in the Middle East: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
    • TABLE 175: The Middle East Melanoma Therapeutics Market Estimates and Forecasts in US$ Million by Therapy: 2018 to 2025
    • TABLE 176: The Middle East Melanoma Therapeutics Historic Market by Therapy in US$ Million: 2009-2017
    • TABLE 177: Melanoma Therapeutics Market in the Middle East: Percentage Share Breakdown of Sales by Therapy for 2009, 2019, and 2025
  • IRAN
    • TABLE 178: Iranian Market for Melanoma Therapeutics: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025
    • TABLE 179: Melanoma Therapeutics Market in Iran: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017
    • TABLE 180: Iranian Melanoma Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025
    • TABLE 181: Iranian Market for Melanoma Therapeutics: Annual Sales Estimates and Projections in US$ Million by Therapy for the Period 2018-2025
    • TABLE 182: Melanoma Therapeutics Market in Iran: Historic Sales Analysis in US$ Million by Therapy for the Period 2009-2017
    • TABLE 183: Iranian Melanoma Therapeutics Market Share Analysis by Therapy: 2009 VS 2019 VS 2025
  • ISRAEL
    • TABLE 184: Israeli Melanoma Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018-2025
    • TABLE 185: Melanoma Therapeutics Market in Israel in US$ Million by Type: A Historic Review for the Period 2009-2017
    • TABLE 186: Israeli Melanoma Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 187: Israeli Melanoma Therapeutics Market Estimates and Forecasts in US$ Million by Therapy: 2018-2025
    • TABLE 188: Melanoma Therapeutics Market in Israel in US$ Million by Therapy: A Historic Review for the Period 2009-2017
    • TABLE 189: Israeli Melanoma Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025
  • SAUDI ARABIA
    • TABLE 190: Saudi Arabian Melanoma Therapeutics Market Growth Prospects in US$ Million by Type for the Period 2018-2025
    • TABLE 191: Melanoma Therapeutics Historic Market Analysis in Saudi Arabia in US$ Million by Type: 2009-2017
    • TABLE 192: Saudi Arabian Melanoma Therapeutics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 193: Saudi Arabian Melanoma Therapeutics Market Growth Prospects in US$ Million by Therapy for the Period 2018-2025
    • TABLE 194: Melanoma Therapeutics Historic Market Analysis in Saudi Arabia in US$ Million by Therapy: 2009-2017
    • TABLE 195: Saudi Arabian Melanoma Therapeutics Market by Therapy: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED ARAB EMIRATES
    • TABLE 196: Melanoma Therapeutics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
    • TABLE 197: United Arab Emirates Melanoma Therapeutics Historic Market Analysis in US$ Million by Type: 2009-2017
    • TABLE 198: Melanoma Therapeutics Market Share Distribution in United Arab Emirates by Type: 2009 VS 2019 VS 2025
    • TABLE 199: Melanoma Therapeutics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Therapy for the Period 2018-2025
    • TABLE 200: United Arab Emirates Melanoma Therapeutics Historic Market Analysis in US$ Million by Therapy: 2009-2017
    • TABLE 201: Melanoma Therapeutics Market Share Distribution in United Arab Emirates by Therapy: 2009 VS 2019 VS 2025
  • REST OF MIDDLE EAST
    • TABLE 202: Melanoma Therapeutics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
    • TABLE 203: Rest of Middle East Melanoma Therapeutics Historic Market Analysis in US$ Million by Type: 2009-2017
    • TABLE 204: Rest of Middle East Melanoma Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 205: Melanoma Therapeutics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Therapy for the Period 2018-2025
    • TABLE 206: Rest of Middle East Melanoma Therapeutics Historic Market Analysis in US$ Million by Therapy: 2009-2017
    • TABLE 207: Rest of Middle East Melanoma Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025
  • AFRICA
    • TABLE 208: African Melanoma Therapeutics Market Estimates and Projections in US$ Million by Type: 2018 to 2025
    • TABLE 209: Melanoma Therapeutics Market in Africa by Type: A Historic Review in US$ Million for 2009-2017
    • TABLE 210: African Melanoma Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 211: African Melanoma Therapeutics Market Estimates and Projections in US$ Million by Therapy: 2018 to 2025
    • TABLE 212: Melanoma Therapeutics Market in Africa by Therapy: A Historic Review in US$ Million for 2009-2017
    • TABLE 213: African Melanoma Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

IV. COMPETITION

  • AMGEN
  • ASTRAZENECA PLC
  • BRISTOL-MYERS SQUIBB COMPANY
  • EISAI CO.
  • F. HOFFMANN-LA ROCHE AG
  • IOVANCE BIOTHERAPEUTICS, INC.
  • MERCK & CO., INC.
  • NOVARTIS INTERNATIONAL AG
  • PFIZER

V. CURATED RESEARCH

Back to Top